CTOs on the Move

Elixir Medical

www.elixirmedical.com

 
Elixir Medical Corporation, a privately-funded company based in Milpitas, California, develops next-generation platforms to treat coronary and peripheral artery disease that are designed to restore the adaptive remodeling and pulsatile motion capabilities of the blood vessel. The company`s mission is to transform the care of patients with heart and vascular disease through innovation.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

American I.V.Products

American I.V.Products is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Eckert and Ziegler Isotope Products (EZIP)

Eckert and Ziegler Isotope Products (EZIP) is a Valencia, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

VIDA Diagnostics

VIDA is the established leader in quantitative pulmonary imaging analysis offering a unique lung imaging evaluation as a service to aid in the early detection, diagnosis, and treatment evaluation of pulmonary diseases.

SpineAlign Medical

SpineAlign Medical Inc. is an early-stage medical device company dedicated to improving patient outcomes through the development of innovative, minimally-invasive products to treat disorders of the spine.

Median Technologies

Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. As The Imaging Phenomics Company®, Median provides insights into novel therapies and treatment strategies. Our unique solutions, MediScan® for lesion management in patient care, Lesion Management Solution (LMS) for lesion detection, measurement and reporting in clinical trials, and our imaging phenotyping system iBiopsy®, together with our global team of experts, are advancing the development of new drugs and diagnostic tools to monitor disease and assess response to therapy. Median Technologies supports biopharmaceutical sponsors and healthcare professionals around the world in bringing new and targeted treatments to patients in need with an eye on reducing overall costs. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a US subsidiary in Boston, Median has received the label “Innovative company” by the BPI and is listed on Euronext Paris` Alternext market (ISIN: FR0011049824, ticker: ALMDT). The company is eligible for the PEA-PME SME equity savings plan setup and has received the label Pass French Tech Promotion 2016-2017.